Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-18

Clinical Trial Update: Effect of Noninvasive Neuromodulation on Chronic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on noninvasive neuromodulation for-temporomandibular dysfunction (TMD) showing ongoing investigation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federal University of Paraíba | Conditions: Temporomandibular Dysfunction (TMD) | Phase 2 | Status: UNKNOWN